These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 5005541)

  • 1. [Pharmacokinetics of cephalothin].
    Höffler D; Koeppe P; Fuchs E; Fiegel P
    Verh Dtsch Ges Inn Med; 1971; 77():1019-22. PubMed ID: 5005541
    [No Abstract]   [Full Text] [Related]  

  • 2. [Blood levels of cephalothin in normal and impaired renal function].
    Höffler D; Koeppe P; Fuchs E; Fiegel P
    Int Z Klin Pharmakol Ther Toxikol; 1972 Feb; 5(4):450-9. PubMed ID: 4625697
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapy with cephaloridine in renal impairment.
    Bechtol LD
    Curr Ther Res Clin Exp; 1972 Dec; 14(12):790-800. PubMed ID: 4629818
    [No Abstract]   [Full Text] [Related]  

  • 4. [Nil nocere. On the problem of the nephrotoxicity of cephaloridine].
    Straube W; König K
    Munch Med Wochenschr; 1969 Mar; 111(12):665-9. PubMed ID: 5819271
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of the kidney with the use of EDTA-Cr51].
    Efimov ON; Baĭchorov EO; Akimtseva NI; Pavlov BD
    Med Radiol (Mosk); 1971 Feb; 16(2):8-12. PubMed ID: 5006241
    [No Abstract]   [Full Text] [Related]  

  • 6. [Relationship between plasma cephalothin clearance and endogenous creatinine clearance. V].
    Sieniawska M; Wróblewska-Kałuzewska M; Białasik D; Karczeńska J; Wierzba K
    Pediatr Pol; 1980 Jun; 55(6):699-705. PubMed ID: 7413318
    [No Abstract]   [Full Text] [Related]  

  • 7. Human pharmacokinetics of cephalexin.
    Bergan T; Midtvedt T; Erikssen J
    Pharmacology; 1970; 4(5):264-72. PubMed ID: 5490473
    [No Abstract]   [Full Text] [Related]  

  • 8. The pharmacokinetics of unchanged pindolol in patients with impaired renal function.
    Ohnhaus EE
    Br J Pharmacol; 1973 Mar; 47(3):620P-621P. PubMed ID: 4730841
    [No Abstract]   [Full Text] [Related]  

  • 9. Fibrin penetration by cephalothin and cephaloridine. An in vitro comparison.
    O'Connell CJ
    J Med; 1971; 2(4):211-6. PubMed ID: 5291106
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum and dialyzate concentrations of intraperitoneal cephalothin in patients undergoing continuous ambulatory peritoneal dialysis.
    Münch R; Steurer J; Lüthy R; Siegenthaler W; Kuhlmann U
    Clin Nephrol; 1983 Jul; 20(1):40-3. PubMed ID: 6883818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of cephalothin and cephalexin in selected avian species.
    Bush M; Locke D; Neal LA; Carpenter JW
    Am J Vet Res; 1981 Jun; 42(6):1014-7. PubMed ID: 7283231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of cephalothin: accumulation of its deacetylated metabolite in uremic patients.
    Nilsson-Ehle I; Nilsson-Ehle P
    J Infect Dis; 1979 Jun; 139(6):712-6. PubMed ID: 448197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Simple chemical methods for the comprehension of kidney function].
    Egger E
    Z Arztl Fortbild (Jena); 1966 Mar; 60(6):300-3. PubMed ID: 5992469
    [No Abstract]   [Full Text] [Related]  

  • 14. Measurement of the kidney function in patients with rheumatoid arthritis: plasma cystatin C versus 51Cr-EDTA clearance.
    Karstila K; Harmoinen AP; Lehtimäki TJ; Korpela MM; Mustonen JT; Saha HH
    Nephron Clin Pract; 2008; 108(4):c284-90. PubMed ID: 18434750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The insulin half-life as a kidney function test].
    Goll KH; Lück G
    Z Urol Nephrol; 1975 Dec; 68(12):927-33. PubMed ID: 1227184
    [No Abstract]   [Full Text] [Related]  

  • 16. [The pharmacokinetics of cephalothin during the late stage of pregnancy and in the course of labour (author's transl)].
    Peiker G; Schröder S; Voigt R; Müller B; Nöschel H
    Pharmazie; 1980 Dec; 35(12):790-3. PubMed ID: 7208583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacology of cefamandole in patients with reduced renal function.
    Czerwinski AW; Pederson JA
    Scand J Infect Dis Suppl; 1980; suppl 25():45-8. PubMed ID: 6937951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum elimination of HES in moderately reduced renal function].
    Schimetta W; Kröll W; Pölz W; Colombo T; Gassmayr SE; Sirtl C; List WF
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Aug; 37(8):468-74. PubMed ID: 12165916
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cephalothin dosage for children depending on the degree of renal failure and body weight VI].
    Sieniawska M; Wróblewska-Kałuzewska M; Białasik D; Wierzba K
    Pediatr Pol; 1980 Jun; 55(6):707-13. PubMed ID: 7413319
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dosing of drugs in disordered kidney function].
    Kudrin AN; Davydova ON; Androsova SO
    Sov Med; 1980; (2):69-81. PubMed ID: 7361189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.